IL-1, including IL-1β, potently induces tumour angiogenesis and invasion by promoting the release of VEGF and MMPs by glioma cells as well as the polarisation and recruitment of immunosuppressive TAMs [23, 24]. The gene discussed is IL1B; the disease is central nervous system cancer.